HuGE Literature Finder
Records
1
-
4
Role of CCL5 and CCR5 gene polymorphisms in epidermal growth factor receptor signalling blockade in metastatic colorectal cancer: analysis of the FIRE-3 trial. European journal of cancer (Oxford, England : 1990) 2019 Jan 107 100-114. Suenaga Mitsukuni, Stintzing Sebastian, Cao Shu, Zhang Wu, Yang Dongyun, Ning Yan, Okazaki Satoshi, Berger Martin D, Miyamoto Yuji, Schirripa Marta, Soni Shivani, Barzi Afsaneh, Heinemann Volker, Lenz Heinz-Jos |
Genetic variants in CCL5 and CCR5 genes and serum VEGF-A levels predict efficacy of bevacizumab in metastatic colorectal cancer patients. International journal of cancer 2019 05 144 (10): 2567-2577. Suenaga Mitsukuni, Cao Shu, Zhang Wu, Yang Dongyun, Ning Yan, Okazaki Satoshi, Berger Martin D, Miyamoto Yuji, Schirripa Marta, Soni Shivani, Barzi Afsaneh, Yamaguchi Toshiharu, Lenz Heinz-Jos |
Gene Polymorphisms in the CCL5/CCR5 Pathway as a Genetic Biomarker for Outcome and Hand-Foot Skin Reaction in Metastatic Colorectal Cancer Patients Treated With Regorafenib. Clinical colorectal cancer 2018 Feb . Suenaga Mitsukuni, Schirripa Marta, Cao Shu, Zhang Wu, Yang Dongyun, Ning Yan, Cremolini Chiara, Antoniotti Carlotta, Borelli Beatrice, Mashima Tetsuo, Okazaki Satoshi, Berger Martin D, Miyamoto Yuji, Gopez Roel, Barzi Afsaneh, Lonardi Sara, Yamaguchi Toshiharu, Falcone Alfredo, Loupakis Fotios, Lenz Heinz-Jos |
Potential Molecular Cross Talk Among CCR5 Pathway Predicts Regorafenib Responsiveness in Metastatic Colorectal Cancer Patients. Cancer genomics & proteomics 0 18 (3): 317-324. Suenaga Mitsukuni, Zhang W U, Mashima Tetsuo, Schirripa Marta, Cao Shu, Okazaki Satoshi, Berger Martin D, Miyamoto Yuji, Barzi Afsaneh, Yamaguchi Toshiharu, Lenz Heinz-Jos |
- Page last reviewed:Oct 1, 2021
- Page last updated:Jun 28, 2022
- Content source: